| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.79T | 2.78T | 2.34T | 1.69T | 1.27T | 1.23T |
| Gross Profit | 1.48T | 1.51T | 1.21T | 1.14T | 1.16T | 1.09T |
| EBITDA | 367.01B | 404.16B | 142.56B | 312.23B | 266.72B | 242.43B |
| Net Income | 281.77B | 257.63B | 79.20B | 191.00B | 169.08B | 142.20B |
Balance Sheet | ||||||
| Total Assets | 79.72T | 78.25T | 75.88T | 69.02T | 64.63T | 62.16T |
| Cash, Cash Equivalents and Short-Term Investments | 27.50T | 25.17T | 22.83T | 21.60T | 18.22T | 18.49T |
| Total Debt | 18.57T | 31.70T | 17.68T | 12.87T | 13.53T | 12.24T |
| Total Liabilities | 76.56T | 75.12T | 72.74T | 12.87T | 61.89T | 59.44T |
| Stockholders Equity | 3.13T | 3.10T | 3.11T | 2.79T | 2.72T | 2.69T |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 0.00 | 1.40T | 2.55T | -172.08B | 6.49T |
| Operating Cash Flow | 0.00 | 0.00 | 1.47T | 2.62T | -120.26B | 6.55T |
| Investing Cash Flow | -1.76T | -1.76T | -2.58T | 960.27B | -879.21B | -475.49B |
| Financing Cash Flow | -47.59B | 679.22B | -85.75B | -217.51B | -125.08B | -219.72B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥3.47T | 8.79 | 9.31% | 3.31% | 16.24% | 78.76% | |
71 Outperform | ¥14.74T | 10.71 | 9.14% | 2.38% | -3.62% | 23.01% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
64 Neutral | ¥1.59T | 12.21 | 7.83% | 2.54% | 19.38% | 29.95% | |
63 Neutral | ¥3.90T | 10.69 | 8.37% | 1.80% | 8.28% | 28.63% | |
63 Neutral | ¥8.95T | 14.35 | 5.28% | 2.73% | 2.17% | 9.55% | |
61 Neutral | ¥5.36T | 10.08 | 3.72% | 3.03% | -1.36% | 38.26% |